Years of solid work and successes have given Greenebaum Enterprises the financial strength to support innovation. We believe in leveraging our company’s assets for exciting start-ups that impact the human condition. We are proud to be involved in the following:
WellDoc is developing the next generation of technology solutions to support chronic disease management. Its mission is to improve the lives of people with chronic diseases – and their families by integrating clinical, behavioral and motivational applications of everyday technologies – like internet and cell phone. We recognize the value in engaging patients and healthcare providers in ways that dramatically improve outcomes and significantly reduce healthcare costs.
Profectus is a clinical-stage biotechnology company bringing a fundamental new approach to designing preventative and therapeutic vaccines by finely tuning immune response to the specific target. We recognize the value of Profectus’ innovative approaches to deadly diseases including Ebola, for which research is currently well underway.